Skip to main content
AstraZeneca PLC logo

AstraZeneca PLC — Investor Relations & Filings

Ticker · AZN ISIN · GB0009895292 LEI · PY6ZZQWO2IZFZC3IOL08 IL Manufacturing
Open in API
Filings indexed 3,403 across all filing types
Latest filing 2019-05-08 Board/Management Inform…
Country GB United Kingdom
Listing IL AZN

About AstraZeneca PLC

https://www.astrazeneca.com/

AstraZeneca PLC is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialization of prescription medicines. The company's portfolio is concentrated on several main therapy areas, including Oncology; Cardiovascular, Renal & Metabolism; and Respiratory & Immunology. AstraZeneca is committed to advancing healthcare through a robust research and development pipeline, aiming to deliver innovative medicines that address significant unmet medical needs for millions of patients worldwide. The company leverages scientific innovation to transform the future of healthcare and improve patient outcomes.

Recent filings

Filing Released Lang Actions
Director Declaration
Board/Management Information Classification · 95% confidence The document is identified by the 'RNS Number' header and contains an announcement dated 08 May 2019 regarding a director's re-election following an AGM of another company (L'Air Liquide S.A.). The content specifically details a transaction or event related to a director's position, which falls under insider activity or director announcements. The filing explicitly mentions 'Director Declaration' and cites Listing Rule 9.6.14 R (2), which often relates to director interests or dealings. While it mentions an AGM, the core subject is the director's status change. This is most closely aligned with 'Director's Dealing' (DIRS) as it concerns a director's official capacity/activities, or potentially 'Board/Management Information' (MANG). Given the specific nature of reporting director changes/interests, DIRS is a strong candidate, although DIRS usually implies share trades. Since it is a formal announcement published via RNS about a director's status change, and it is not a general regulatory filing (RNS) or a management change (MANG), 'Director's Dealing' (DIRS) is the most specific fit for reporting director-related events, even if it's not a share trade, as it's a declaration related to a director's role. However, looking closely at the definitions, 'Director's Dealing' (DIRS) is for personal share transactions. This is a declaration about a director's re-election to another board. 'Board/Management Information' (MANG) covers changes in the board of directors. Since this is a declaration about a Non-Executive Director's status change (re-election), MANG is the most appropriate category for reporting director-related governance events not covered by share trades or remuneration. The document is short and published via RNS, but the content is specific enough to classify beyond RNS.
2019-05-08 English
TRASTUZUMAB DERUXTECAN DEMONSTRATED CLINICALLY
Regulatory Filings
2019-05-08 English
CALQUENCE PHIII ASCEND TRIAL MET PRIMARY ENDPOINT
Regulatory Filings
2019-05-07 English
QTERNMET XR APPROVED IN THE US FOR TYPE-2 DIABETES
Regulatory Filings
2019-05-03 English
Qternmet XR approved in the US for type-2 diabetes
Regulatory Filings Classification · 98% confidence The document is identified by the 'RNS Number' header and explicitly states, 'This information is provided by RNS, the news service of the London Stock Exchange.' It announces a specific corporate event—the FDA approval of a drug (Qternmet XR)—which is a material piece of news for investors. Since this is a general regulatory announcement that doesn't fit neatly into specific financial report categories (like 10-K, ER, or IR), and it is distributed via the RNS system, the most appropriate classification is the general Regulatory Filings category (RNS). The document length is short (under 5,000 characters), but it is the primary announcement itself, not an announcement *about* another report, so the RPA rule does not strictly apply here over RNS for this type of news release.
2019-05-03 English
TOTAL VOTING RIGHTS
Regulatory Filings
2019-05-01 English

Browse filings by year

34 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.